The executive committee briefing
Proposed decision: align every public statement with the actual level of evidence, intended audience and project status.
The risk to be prevented
A scientific breakthrough may give rise to hope before its benefits, limits or conditions of access are established. The problem arises when the institutional narrative erases these distinctions. The organization's reputation then depends on its ability to explain what is known and what remains to be demonstrated, without bringing this nuance to the technical document alone.
Recommended decision
Set up a joint review between medical or scientific management, regulatory affairs, legal affairs, market access and communication. This review examines the formulation, population concerned, type of outcome and limits. It distinguishes scientific information, institutional communication and promotional content according to the applicable rules.
Decisions expected
Identify the owner of the evidence and the person responsible for its translation for each public. Define events that require updating, correction or suspension of content. Provide a response process when knowledge evolves, as well as an orientation circuit of individual questions to the appropriate interlocutors.
Make the level of evidence visible
Intelligibility is not about removing uncertainty, but about giving it an understandable form.
Do not confuse different steps
A hypothesis, an exploratory outcome, a clinical trial and an authorisation decision are not interchangeable. Similarly, a result on a given criterion does not automatically describe all the benefits expected by patients. Communication must preserve the distinctions necessary for understanding, including when a short title or interview invites them to be simplified.
Transparency changes how information is read
The EMA describes arrangements for publishing clinical data and clinical-trial information, each with a different scope [1]. CTIS and its public portal make some of this information accessible [2]. Audiences can therefore compare an institutional message with other documents. Editorial work must connect these layers, rather than assume a press release will be read in isolation.
Linking evidence and scope of the statement
Before publication, specify the population studied, the comparator where it exists, the criterion observed, the duration of follow-up and the main limits. All these elements do not have the same place in each format, but no main message should contradict their meaning. When a result does not allow a conclusion, the narrative must retain this boundary.
Building an editorial evidence chain
The communications department must be able to go back from a public sentence to its scientific basis and validation.
Starting from the public question
Professionals want to understand the method and clinical relevance. Patients question about benefits, risks and access. Investors examine the trajectory of the project. Public actors look at the needs and collective conditions of use. One message can be accurate for one audience and incomplete for another; it is necessary to adapt the explanation without changing the status of the evidence.
Documenting formulation choices
Retain the source, version, limitations and reasons for editorial simplifications. Identify words that may lead to an unestablished availability, superiority or benefit. Reviewers must have a specific object to validate, with visuals and the context of dissemination.
Provide for the period of validity
Content on a research program can become obsolete after a new result, protocol evolution or authority decision. The publication process must therefore include an owner of the update. The translated versions must evolve together: a correction in French is not enough if an old statement remains visible in another language.
| Level | Editorial question | Meaning to preserve |
|---|---|---|
| Hypothesis | What are we seeking to test? | Research objective |
| Result | What was actually observed? | Population, endpoint and limits |
| Application | Within what framework can we act? | Status and applicable conditions |
Communicate when knowledge changes
The following situations are fictitious: they are used to test the governance of information, without giving medical advice.
An encouraging result becomes an excessive title
A scientific presentation is repeated as a promise of available treatment. The organization must quickly specify the stage of development, the exact result and the limits. It can propose a factual correction and an accessible resource. The committee also examines whether the title, visual or phrase of the spokesperson contributed to the interpretation.
New data changes analysis
A subsequent result reduces the scope of an earlier conclusion. The answer must explain what has changed, why interpretation is changing and what content is up-to-date. The normal evolution of knowledge must not be confused with a lack of editorial accountability. The version register helps to show corrections without maintaining two incompatible narratives.
Access becomes the main public subject
An innovation raises expectations while conditions of access remain uncertain. Communication must distinguish between scientific development, regulatory decisions and access procedures. The competent functions specify the steps and responsibilities. A relationship with patient associations should not become a means of making them make a promise that the organization cannot fulfil.
Organize dialogue between science and society
A health organization must make its choices understandable without reducing the audience to recipients of messages.
Linking relevant competencies
Scientists bring the method and limitations. Medical and regulatory teams specify the framework. Patient associations and representatives can shed light on questions of understanding and experience, in transparent relationships. Communication organizes this meeting without delegating scientific validation to the popularity of a narrative.
Preparing media relations
A useful file includes an accessible summary, the results in context, the main limitations and links to references. Spokespersons should be able to distinguish between what falls within their expertise and what requires another interlocutor. Comparisons should be justified; images and testimonies should not suggest more than data.
Linking public affairs and access reality
The institutional dialogue focuses on the collective issues, constraints and decisions identified, making it easier to distinguish between established facts, organizational positions and proposals. Consistency between what is said to authorities, professionals and the general public is a condition of credibility. The committee must be aware of differences in wording justified by the public and those which mask internal disagreement.
Making information findable and unambiguous
In health, misinterpretation of public information can have an important impact on the person who reads it.
An editorial architecture that distinguishes subjects
Separate information on the organisation, research programmes, results and content intended for support and guidance. Indicate the dates, authors or functions responsible and the status of documents. Old pages should refer to relevant updates. Navigation should help to understand whether scientific, institutional or other content is being consulted.
GEO based on source quality
The content must formulate direct responses while maintaining the necessary limits. Links to primary sources facilitate verification. Sound search practices remain relevant for Google's AI features [3], without any guarantee of presence. The work is not to multiply repetitive pages on a pathology, but to make authorized information consistent and accessible.
Observe errors with consequence
Testing questions about the status of a program, the scope of an outcome and the distinction between the organization and its products. Using general cases without individual health data. Identifying the confusions and sources cited. An increased presence in AI responses is not a success if it accompanies a more affirmative representation than the evidence.
90 days to build the editorial chain
The proposed programme links publication, scientific review and follow-up of interpretations.
First month — Map the evidence
Select the most exposed programs and content. Link each statement to its source and status. Identify language versions, old pages and elements taken up by partners. Identify formulations whose scope exceeds data and important information difficult to find.
Second month — Test the process
Organize a cross-review of messages with people who have not participated in their writing. Ask them what they understand about benefits, limits and access. Simulate the appearance of new data and verify the ability to correct all media involved. Train spokespersons to explain uncertainty without masking or making it incomprehensible.
Third month — Install
Update priority content and formalize responsibilities. Build a list of review triggers and a control schedule. The committee examines corrected deviations, topics that remain open and the necessary review resources. Language versions are followed as full publications, with their own checks for meaning.
What the committee should require
The quality of the communication is judged by the fidelity of the explanation and the ability to review.
Governance indicators
Follow priority content related to a valid source, correction times and differences between language versions. Examine recurring questions that reveal misunderstanding. Distinguish factual error, ambiguity and disagreement about organizational choices: they do not call for the same answer.
The limits of assessment
The volume of readings does not demonstrate understanding or support. A favorable comment does not validate a scientific interpretation. The measure must be supplemented by qualitative reviews and competent functions. The recommendations in this file relate to the governance of communication, not a care decision or clinical conclusion.
The decision to formalize
Validate the owner of each content family, the revision procedure and the review resources. Ask for an example of successful simplification and an example of rejected formulation because it exceeded the data. These cases make the doctrine observable.
Sources and reference points
- EMA — Clinical data publication
- EMA — Clinical Trials Information System (CTIS)
- Google Search Central — AI features and your website
Analysis and recommendations by Belief System. Scenarios are illustrative. Sources provide context; they do not constitute endorsement of our recommendations.